TOPIRAMATE
NDC 72603-121, topiramate, capsule, extended release, from NorthStar RxLLC.
- Product NDC
- 72603-121
- Status
- Listed
- Labeler
- NorthStar RxLLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA210278
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/72603-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- TOPIRAMATE50 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A4 Inducers [MoA]; Decreased Central Nervous System Disorganized Electrical Activity [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 72603-121-01 | 72603012101 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (72603-121-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/b5f8da43-6daf-413c-9dcd-363617973738NADAC price for package 72603012101
GET /v1/drugs/nadac/72603012101
Use it
Look up 72603-121 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/72603-121 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 72603-121. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.